Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Abaxis Signs Exclusive Distribution Agreement with Abbott

By LabMedica International staff writers
Posted on 05 Nov 2012
Abaxis, Inc. More...
(Union City, CA, USA) signed an exclusive multiyear distribution agreement with Abbott's Point-of-Care (POC; Princeton, NJ, USA) business to market and distribute the Piccolo Xpress, a portable clinical chemistry system, and its full line of one-time user reagent discs, to the human medical market.

Abbott will have the exclusive right to distribute and sell Abaxis' Piccolo Xpress chemistry analyzer and associated consumables in the US and China (including Hong Kong). Abaxis will retain the distribution rights to current customer Catapult Health (Dallas, TX, USA) and certain segments including pharmacy and retail store clinics, shopping malls, contract research organizations (CROs), and cruise ship lines. The company will provide technical support and warranty services to support Abbott's commercial efforts.

The Piccolo Xpress provides on-the-spot chemistry results in minutes. About the size of a shoebox, health care providers use the Piccolo Xpress's easy-to-follow color touch-screen commands to perform routine multi-chemistry panels. 0.1 mL of whole blood, serum, or plasma is added directly to the single use plastic disc containing the liquid diluent and dry reagents. The disc is placed in the analyzer drawer where centrifugal and capillary forces are used to mix the reagents and sample in the disc. The Piccolo Xpress monitors the reagent reactions simultaneously using nine wavelengths, calculates the results from the absorbance data, and reports the results. The easy-to-use, low maintenance system requires no special training to operate.

Abaxis develops, manufactures, markets, and sells portable blood analysis systems for use in any human patient-care or veterinary setting to provide clinicians with rapid blood constituent measurements.

Related Links:
Abaxis
Abbott's Point-of-Care


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.